- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- New alliance will crack down on adulterated products touting dietary supplement claims
- Moving PSE to Rx-only in Mo. lacks fiscal sense
- Walgreens launches high-impact push in support of World AIDS Day campaign
- Merck's hepatitis C drug granted priority review by FDA
AMITYVILLE, N.Y. — The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.
The agency approved Hi-Tech’s sterile lidocaine jelly in the 2% strength, used for treating pain in procedures involving the urethra, painful urethritis and in endotracheal intubation.
Various versions of the drug had sales of $17 million in 2010, according to IMS Health.